Prescreening of prostate cancer by serum prostatic specific...

Details Prescreening of prostate cancer by serum prostatic specific... Prescreening of prostate cancer by serum prostatic specific...

G - Physics

01

N

G01N 33/577 (2006.01) G01N 33/574 (2006.01) G01N 33/96 (2006.01)

Patent

CA 2100464

A method of prescreening for possible prostate cancer comprises measuring serum specific antigen (PSA) concentration and comparing that concentration to a specific threshold value to identify a subpopulation of men having a high risk of the presence of prostate cancer, thus suggesting more extensive diagnostic procedures to confirm or eliminate diagnosis of prostate cancer.

Affiliated with

Also associated with

Rating

Prescreening of prostate cancer by serum prostatic specific... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prescreening of prostate cancer by serum prostatic specific..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prescreening of prostate cancer by serum prostatic specific... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1467833